Hostname: page-component-6766d58669-vgfm9 Total loading time: 0 Render date: 2026-05-17T16:23:16.160Z Has data issue: false hasContentIssue false

New treatment strategy and assessment questionnaire for external auditory canal pruritis: topical pimecrolimus therapy and Modified Itch Severity Scale

Published online by Cambridge University Press:  19 November 2009

B Acar*
Affiliation:
Department of Otorhinolaryngology, Kecioren Training and Research Hospital, Ankara, Turkey
H Karabulut
Affiliation:
Department of Otorhinolaryngology, Kecioren Training and Research Hospital, Ankara, Turkey
Y Sahin
Affiliation:
Department of Otorhinolaryngology, Kecioren Training and Research Hospital, Ankara, Turkey
M A Babademez
Affiliation:
Department of Otorhinolaryngology, Kecioren Training and Research Hospital, Ankara, Turkey
A S Karadag
Affiliation:
Department of Dermatology, Kecioren Training and Research Hospital, Ankara, Turkey
R M Karasen
Affiliation:
Department of Otorhinolaryngology, Kecioren Training and Research Hospital, Ankara, Turkey
*
Address for correspondence: Dr Baran Acar, Department of Otorhinolaryngology, Kecioren Training and Research Hospital, Pınarbaşı mahallesi sanatoryum caddesi Ardahan sok no 1, Keçiören, 06310, Ankara, Turkey. Fax: +90 312 356 90 22 E-mail: drbaranacar@gmail.com

Abstract

Objective:

We aimed to compare the efficacy of topical pimecrolimus versus hydrocortisone in treating external auditory canal pruritis, using the Modified Itch Severity Scale as an assessment tool.

Methods:

We included in the study 40 patients with isolated itching of the external auditory canal who had not received any benefit from previous topical and systemic treatments. Topical 1 per cent pimecrolimus or topical hydrocortisone was applied to each patient's external auditory canal for three months. A Modified Itch Severity Scale was developed and used to assess treatment response.

Results:

Compared with itching scores on initial assessment, the scores of patients receiving topical pimecrolimus had decreased by 52.3 per cent by the third week of treatment and by 77.6 per cent by the third month, whereas the scores of patients receiving topical hydrocortisone had decreased by 34.4 per cent by the third week and by 64.2 per cent by the third month.

Conclusions:

Topical pimecrolimus appears to be as effective as topical hydrocortisone in relieving external auditory canal pruritis. We used a novel scoring system, the Modified Itch Severity Scale, to evaluate external auditory canal pruritus; this is the first self-reporting questionnaire for the quantification of external auditory canal pruritus severity. Further studies are needed to validate this scoring system.

Information

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable